{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:04:07Z","timestamp":1789016647203,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008258","name":"Hyundai Hope on Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA194864"],"award-info":[{"award-number":["R01 CA194864"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA212608"],"award-info":[{"award-number":["R01 CA212608"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA245502"],"award-info":[{"award-number":["R01 CA245502"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21 CA246457"],"award-info":[{"award-number":["R21 CA246457"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21 AI158997"],"award-info":[{"award-number":["R21 AI158997"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006732","name":"New York University","doi-asserted-by":"publisher","award":["US 63\/174,131"],"award-info":[{"award-number":["US 63\/174,131"]}],"id":[{"id":"10.13039\/100006732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jmb.2021.167402","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T03:03:23Z","timestamp":1640315003000},"page":"167402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"434","author":[{"given":"Larizbeth A.","family":"Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.E.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Ketavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2021.167402_b0005","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1964::AID-CNCR27>3.0.CO;2-1","article-title":"Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia","volume":"88","author":"Hurwitz","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jmb.2021.167402_b0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2021.167402_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrd2240","article-title":"New therapeutic strategies for the treatment of acute lymphoblastic leukaemia","volume":"6","author":"Pui","year":"2007","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.jmb.2021.167402_b0020","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","article-title":"Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience","volume":"21","author":"Goldberg","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jmb.2021.167402_b0025","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04584.x","article-title":"Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia","volume":"123","author":"Chessells","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jmb.2021.167402_b0030","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2021.167402_b0035","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","article-title":"T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII\/ECOG 2993)","volume":"114","author":"Marks","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2021.167402_b0040","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O","article-title":"Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy","volume":"86","author":"Thomas","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jmb.2021.167402_b0045","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nature Genet."},{"key":"10.1016\/j.jmb.2021.167402_b0050","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1200\/JCO.2010.30.2877","article-title":"Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition","volume":"29","author":"Szczepanski","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jmb.2021.167402_b0055","doi-asserted-by":"crossref","first-page":"58728","DOI":"10.18632\/oncotarget.11233","article-title":"Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia","volume":"7","author":"Yadav","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmb.2021.167402_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1073\/pnas.83.1.135","article-title":"Cloning an expressed gene shared by the human sex chromosomes","volume":"83","author":"Darling","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2021.167402_b0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1189\/jlb.0210097","article-title":"Death induction by CD99 ligation in TEL\/AML1-positive acute lymphoblastic leukemia and normal B cell precursors","volume":"88","author":"Husak","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jmb.2021.167402_b0070","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1073\/pnas.76.12.6552","article-title":"A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies","volume":"76","author":"Levy","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2021.167402_b0075","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.4049\/jimmunol.166.8.4931","article-title":"CD99 signals caspase-independent T cell death","volume":"166","author":"Pettersen","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165210","article-title":"Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia","volume":"11","author":"Cox","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jmb.2021.167402_b0085","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.leu.2403303","article-title":"CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease","volume":"18","author":"Dworzak","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jmb.2021.167402_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2025","article-title":"CD99 is a therapeutic target on disease stem cells in myeloid malignancies","volume":"9","author":"Chung","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jmb.2021.167402_b0095","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U","article-title":"MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration","volume":"67","author":"Ambros","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jmb.2021.167402_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3","article-title":"Sequence complexity of disordered protein","volume":"42","author":"Romero","year":"2001","journal-title":"Proteins"},{"key":"10.1016\/j.jmb.2021.167402_b0105","first-page":"89","article-title":"The protein non-folding problem: amino acid determinants of intrinsic order and disorder","author":"Williams","year":"2001","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.jmb.2021.167402_b0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/prot.10437","article-title":"Flavors of protein disorder","volume":"52","author":"Vucetic","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.jmb.2021.167402_b0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt785","article-title":"Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library","volume":"21","author":"Feldhaus","year":"2003","journal-title":"Nature Biotechnol."},{"key":"10.1016\/j.jmb.2021.167402_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2006.94","article-title":"Isolating and engineering human antibodies using yeast surface display (vol 1, pg 755, 2006)","volume":"1","author":"Chao","year":"2006","journal-title":"Nature Protocols"},{"key":"10.1016\/j.jmb.2021.167402_b0125","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167402_b0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-62703-992-5_20","article-title":"Reformatting of scFv Antibodies into the scFv-Fc Format and Their Downstream Purification","volume":"1131","author":"Bujak","year":"2014","journal-title":"Monoclonal Antibodies: Methods and Protocols"},{"key":"10.1016\/j.jmb.2021.167402_b0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0019-2791(72)90097-3","article-title":"The influence of polyvalency on the binding properties of antibodies","volume":"9","author":"Crothers","year":"1972","journal-title":"Immunochemistry"},{"key":"10.1016\/j.jmb.2021.167402_b0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6750-9-14","article-title":"A multi-Fc-species system for recombinant antibody production","volume":"9","author":"Moutel","year":"2009","journal-title":"BMC Biotech."},{"key":"10.1016\/j.jmb.2021.167402_b0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-1119(03)00401-3","article-title":"Cloning, genomic organization, alternative transcripts and expression analysis of CD99L2, a novel paralog of human CD99, and identification of evolutionary conserved motifs","volume":"307","author":"Suh","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.jmb.2021.167402_b0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng1194-285","article-title":"Pbdx Is the Xg Blood-Group Gene","volume":"8","author":"Ellis","year":"1994","journal-title":"Nature Genet."},{"key":"10.1016\/j.jmb.2021.167402_b0155","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/eji.1830190813","article-title":"The biochemical characterization of E2, a T cell surface molecule involved in rosettes","volume":"19","author":"Aubrit","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0160","doi-asserted-by":"crossref","first-page":"15837","DOI":"10.1074\/jbc.M111.286633","article-title":"Evolutionarily conserved paired immunoglobulin-like receptor alpha (PILRalpha) domain mediates its interaction with diverse sialylated ligands","volume":"287","author":"Sun","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2021.167402_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166748","article-title":"The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition","volume":"433","author":"Hattori","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167402_b0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jmb.2012.09.022","article-title":"Broad ranges of affinity and specificity of anti-histone antibodies revealed by a quantitative Peptide immunoprecipitation assay","volume":"424","author":"Nishikori","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167402_b0175","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.1248943","article-title":"Complement is activated by IgG hexamers assembled at the cell surface","volume":"343","author":"Diebolder","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167402_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002344","article-title":"A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface","volume":"14","author":"de Jong","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jmb.2021.167402_b0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-2478(99)00165-0","article-title":"CD99 monoclonal antibody induce homotypic adhesion of Jurkat cells through protein tyrosine kinase and protein kinase C-dependent pathway","volume":"71","author":"Kasinrerk","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jmb.2021.167402_b0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.154.1.26","article-title":"The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes","volume":"154","author":"Bernard","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/hyb.2007.0504","article-title":"Production, characterization, and functional analysis of newly established CD99 monoclonal antibodies MT99\/1 and MT99\/2","volume":"26","author":"Khunkaewla","year":"2007","journal-title":"Hybridoma (Larchmt)"},{"key":"10.1016\/j.jmb.2021.167402_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085980","article-title":"CADM1 controls actin cytoskeleton assembly and regulates extracellular matrix adhesion in human mast cells","volume":"9","author":"Moiseeva","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jmb.2021.167402_b0205","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0021-9258(19)41672-4","article-title":"The essential role of Ca2+ in the activity of bovine pancreatic deoxyribonuclease","volume":"250","author":"Price","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2021.167402_b0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molcel.2016.05.016","article-title":"Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen","volume":"63","author":"Wang","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jmb.2021.167402_b0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nmeth861","article-title":"A monovalent streptavidin with a single femtomolar biotin binding site","volume":"3","author":"Howarth","year":"2006","journal-title":"Nature Methods"},{"key":"10.1016\/j.jmb.2021.167402_b0220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-540-72843-6_17","article-title":"Proline-rich sequence recognition domains (PRD): ligands, function and inhibition","author":"Freund","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jmb.2021.167402_b0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1096\/fasebj.14.2.231","article-title":"The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains","volume":"14","author":"Kay","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.jmb.2021.167402_b0230","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature24036","article-title":"Human TRPML1 channel structures in open and closed conformations","volume":"550","author":"Schmiege","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2021.167402_b0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcc.21303","article-title":"Crystal contacts as nature's docking solutions","volume":"31","author":"Krissinel","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmb.2021.167402_b0240","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2021.167402_b0245","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/BJ20050411","article-title":"Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction","volume":"390","author":"Li","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmb.2021.167402_b0250","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jmb.2021.167402_b0255","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","article-title":"Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801","volume":"109","author":"DeAngelo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2021.167402_b0260","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmb.2021.167402_b0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.annonc.2019.09.004","article-title":"Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)","volume":"31","author":"Kundranda","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jmb.2021.167402_b0270","article-title":"Phase 1a study results investigating the safety and preliminary efficacy of ABL001 (NOV1501), a bispecific antibody targeting VEGF and DLL4 in metastatic gastrointestinal (GI) cancer","volume":"37","author":"Lee","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jmb.2021.167402_b0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jmb.2021.167402_b0280","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI92981","article-title":"The NOTCH1\/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model","volume":"128","author":"Garcia-Peydro","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jmb.2021.167402_b0285","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/cas.13859","article-title":"NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia","volume":"110","author":"Kimura","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jmb.2021.167402_b0290","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nature Med."},{"key":"10.1016\/j.jmb.2021.167402_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.02.001","article-title":"Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling","volume":"176","author":"Pan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2021.167402_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.569684","article-title":"The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors","volume":"8","author":"Zhao","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jmb.2021.167402_b0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/intimm\/dxh353","article-title":"A humanized anti-human Fas antibody, R-125224, induces apoptosis in type I activated lymphocytes but not in type II cells","volume":"18","author":"Nakayama","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0310","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/19420862.2019.1625662","article-title":"Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members","volume":"11","author":"Yang","year":"2019","journal-title":"Mabs"},{"key":"10.1016\/j.jmb.2021.167402_b0315","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.4049\/jimmunol.158.6.2543","article-title":"Apoptosis of immature thymocytes mediated by E2\/CD99","volume":"158","author":"Bernard","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0320","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0014-5793(03)01224-9","article-title":"The CD99 signal enhances Fas-mediated apoptosis in the human leukemic cell line, Jurkat","volume":"554","author":"Jung","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jmb.2021.167402_b0325","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/emm.2002.58","article-title":"Characterization and epitope mapping of two monoclonal antibodies against human CD99","volume":"34","author":"Gil","year":"2002","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jmb.2021.167402_b0330","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4049\/jimmunol.143.2.526","article-title":"Igg3 Is the Major Source of Cryoglobulins in Mice","volume":"143","author":"Abdelmoula","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0335","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3389\/fimmu.2018.01096","article-title":"CH2 Domain of Mouse IgG3 Governs Antibody Oligomerization, Increases Functional Affinity to Multivalent Antigens and Enhances Hemagglutination","volume":"9","author":"Klaus","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2021.167402_b0340","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1073\/pnas.95.7.3816","article-title":"High affinity cross-reacting mAb generated by minimal mimicry: implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression","volume":"95","author":"Rothermel","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2021.167402_b0345","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/j.1460-2075.1989.tb08485.x","article-title":"The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product","volume":"8","author":"Gelin","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.jmb.2021.167402_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/antib9040053","article-title":"Structure, Function, and Therapeutic Use of IgM Antibodies","volume":"9","author":"Keyt","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.jmb.2021.167402_b0355","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13045-021-01178-z","article-title":"CAR T cells targeting CD99 as an approach to eradicate T-cell acute lymphoblastic leukemia without normal blood cells toxicity","volume":"14","author":"Shi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jmb.2021.167402_b0360","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.1303640110","article-title":"Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains","volume":"110","author":"Sha","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2021.167402_b0365","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/btpr.174","article-title":"Highly avid magnetic bead capture: an efficient selection method for de novo protein engineering utilizing yeast surface display","volume":"25","author":"Ackerman","year":"2009","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jmb.2021.167402_b0370","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1101\/gr.3.6.S136","article-title":"Mutagenic PCR","volume":"3","author":"Cadwell","year":"1994","journal-title":"PCR Methods Appl."},{"key":"10.1016\/j.jmb.2021.167402_b0375","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nmeth.2605","article-title":"Recombinant antibodies to histone post-translational modifications","volume":"10","author":"Hattori","year":"2013","journal-title":"Nature Methods"},{"key":"10.1016\/j.jmb.2021.167402_b0380","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","article-title":"Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice","volume":"292","author":"Lo","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2021.167402_b0385","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1073\/pnas.82.2.488","article-title":"Rapid and efficient site-specific mutagenesis without phenotypic selection","volume":"82","author":"Kunkel","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2021.167402_b0390","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jmb.2021.167402_b0395","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmb.2021.167402_b0400","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jmb.2021.167402_b0405","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jmb.2021.167402_b0410","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283621006392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283621006392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:23:43Z","timestamp":1762669423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283621006392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022283621006392"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2021.167402","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2021.167402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"167402"}}